Long COVID
238
49
76
99
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
18 trials with published results (8%)
Research Maturity
99 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.8%
2 terminated out of 238 trials
98.0%
+11.5% vs benchmark
3%
8 trials in Phase 3/4
18%
18 of 99 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 99 completed trials
Clinical Trials (238)
RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)
Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID
Attention, Memory and Quality of Life in Post-COVID-19 Adults
tVNS in Long COVID-19
Transcranial Direct Current Stimulation for Long COVID Brain Fog and Fatigue
Characterization of the Immunometabolic Signature in Long COVID-19.
Nutritional Management of Post COVID-19 Cognitive Symptoms
Heat thErapy And mobiLity in COVID-19 Survivors
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome
Long COVID Immune Profiling
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC)
Fatigue in Long COVID
Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
A Pilot Randomized Controlled Trial of Homeopathic Treatment for Long COVID
RECOVER-ENERGIZE Platform Protocol_Appendix A (Exercise Intolerance)
RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)
PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Taurine Supplementation in Adolescents With Post-COVID Condition
Balance Acceptance and Commitment Therapy for Long COVID